Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 7, 2008, Pages 995-1001

  Rahman, Nafisur ^a   Bano, Zehra ^a   Azmi, Syed Najmul Hejaz ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

1 chloro 2,4 dinitrobenzene; 3 methyl 2 benzothiazolinone hydrazone hydrochloride; Quantitative analysis; Rabeprazole sodium; Spectrophotometry; Validation

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 3 METHYL 2 BENZOTHIAZOLINONE HYDRAZONE; CERIUM NITRATE; DIMETHYL SULFOXIDE; RABEPRAZOLE; RABICIP 20; RAPEED 20;

ANALYTIC METHOD; ARTICLE; COMPLEX FORMATION; DRUG DOSAGE FORM; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; VALIDATION PROCESS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; SPECTROPHOTOMETRY; TABLETS; TEMPERATURE; TIME FACTORS;

EID: 46749139915     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.995     Document Type: Article

References (22)

1. Jaworski T., Sarosiek I., Sostarich S., Roeser K., Connor M., Brotze S., Waller G., Sarosiek J., Dig. Dis. Sci., 50, 357-365 (2005).
2. "Martindale The Extra Pharmacopoeia," 34th ed., Royal Pharmaceutical Society, London, 2005, p. 1285.
3. Padmanabha Y., Jayachandra R. P., Prasad R. K. V. S., Prabhakar G., Asian J. Chem., 17, 1025-1030 (2005).
4. Garcia C. V., Paim C. S., Steppe M., J. AOAC Int., 87, 842-846 (2004).
5. Miura M., Tada H., Satoh S., Habuchi T., Suzuki T., J. Pharm. Biomed. Anal., 41, 565-570 (2006).
6. Huang J., Xu Y., Gao S., Rui L., Guo Q., Rapid Commun. Mass Spectrom., 19, 2321-2324 (2005).
7. Garcia C. V., Sippel J., Sfair L. L., Garcia S. S., Joblonski A., Steppe M., Schapoval E. E. S., J. AOAC Int., 88, 1081-1085 (2005).
8. Garcia C. V., Sippel J., Steppe M., Schapoval E. E. S., Anal. Lett., 39, 341-348 (2006).
9. Pattanayak P., Sharma R., Chaturvedi S. C., Anal. Lett., 40, 2288-2294 (2007).
10. El-Gindy A., El-Yazby F., Maher M. M., J. Pharm. Biomed. Anal., 31, 229-242 (2003).
11. Valentina P., Ilango K., Lakshmi K. S., Bhanudepika K., Murugan D., Ikram S. A. S., Satyanarayana I. V. V., Int. J. Chem. Sci., 3, 237-240 (2005).
12. International Conference on Harmonisation, Fed. Regist., 60, 11260 (1995).
13. Canada Health Protection Branch, "Drugs Directorate Guidelines, Acceptable Methods," Ministry of National Health and Welfare, Draft, Ottawa, Canada, 1992.
14. Hartmann C., Smeyers-Verbeke J., Pinninckx W., Heyden Y. V., Vankeerberghen P., Massart D. L., Anal. Chem., 67, 4491-4499 (1995).
15. Revansiddappa H. D., Manju B., Manju P. G., Ramappa P. G., Anal. Sci., 15, 661-664 (1999).
16. Sawicki E., Stanley T. W., Hauser T. R., Elbert W., Noe J. L., Anal. Chem., 33, 722-725 (1961).
17. Sastry C. S. P., Naidu P. Y., Murty S. S. N., Talanta, 44, 1211-1217 (1997).
18. Grimmett M. R., "Comprehensive Organic Chemistry: The Synthesis and Reactions of Organic Compounds," Vol. 4, ed. by Sammes P. G., Pergamon Press, U.K., 1979, p. 371.
19. Bent H. E., French C. L., J. Am. Chem. Soc., 63, 568-572 (1941).
20. Coombes R. G., "Comprehensive Organic Chemistry: The Synthesis and Reactions of Organic Compounds," Vol. 2, ed. by Sutherland I. O., Pergamon Press, U.K., 1979, p. 352.
21. Sheinker V. N., Chernyshev V. A., Garnovskii A. D., Osipov O. A., Zh. Obshch. Khim., 47, 647-650 (1977).
22. Strauss M. J., Chem. Rev., 70, 667-712 (1970).